Literature DB >> 12673045

Inhibitory effect of Perilla leaf extract and luteolin on mouse skin tumor promotion.

Hiroshi Ueda1, Chikako Yamazaki, Masatoshi Yamazaki.   

Abstract

In the present study, the effects of perilla leaf extract (PLE) and luteolin on 7,12-dimethylbenz[a]anthracene (DMBA)- and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin papillomas in mice were investigated. Topical application of PLE prior to TPA treatment in DMBA-initiated mouse skin resulted in a significant reduction in tumor incidence and multiplicity. An even more potent preventive effect was observed with topical application of luteolin, which we previously identified as an antiinflammatory constituent. PLE was dissolved in drinking water at a 0.05% dose and mice ingested it ad libitum; no significant difference was observed in tumor incidence or multiplicity but there was a significant reduction in tumor volume between the PLE-treated and untreated groups. These results suggest that PLE has potent antipromotion activity and ingesting it as a daily food may provide a beneficial chemopreventive effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673045     DOI: 10.1248/bpb.26.560

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  22 in total

Review 1.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  A methoxyflavanone derivative from the Asian medicinal herb (Perilla frutescens) induces p53-mediated G2/M cell cycle arrest and apoptosis in A549 human lung adenocarcinoma.

Authors:  Amer Ali Abd El-Hafeez; Takashi Fujimura; Rikiya Kamei; Noriko Hirakawa; Kenji Baba; Kazuhisa Ono; Seiji Kawamoto
Journal:  Cytotechnology       Date:  2017-07-14       Impact factor: 2.058

3.  A superoxide-mediated mitogen-activated protein kinase phosphatase-1 degradation and c-Jun NH(2)-terminal kinase activation pathway for luteolin-induced lung cancer cytotoxicity.

Authors:  Lang Bai; Xiuling Xu; Qiong Wang; Shanling Xu; Wei Ju; Xia Wang; Wenshu Chen; Weiyang He; Hong Tang; Yong Lin
Journal:  Mol Pharmacol       Date:  2012-01-05       Impact factor: 4.436

4.  "Combination-oriented molecular-targeting prevention" of cancer: a model involving the combination of TRAIL and a DR5 inducer.

Authors:  Tatsushi Yoshida; Mano Horinaka; Toshiyuki Sakai
Journal:  Environ Health Prev Med       Date:  2010-01-06       Impact factor: 3.674

Review 5.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

Review 6.  Hormetic dietary phytochemicals.

Authors:  Tae Gen Son; Simonetta Camandola; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2008-06-10       Impact factor: 3.843

7.  Perilla frutescens Britton var. frutescens leaves attenuate dextran sulfate sodium-induced acute colitis in mice and lipopolysaccharide-stimulated angiogenic processes in human umbilical vein endothelial cells.

Authors:  Yuna Lee; Jungjae Lee; Jihyeung Ju
Journal:  Food Sci Biotechnol       Date:  2019-11-25       Impact factor: 2.391

8.  Flavonoids: A versatile source of anticancer drugs.

Authors:  Maheep K Chahar; Neelu Sharma; Mahabeer P Dobhal; Yogesh C Joshi
Journal:  Pharmacogn Rev       Date:  2011-01

9.  Inhibitory activities of Perilla frutescens britton leaf extract against the growth, migration, and adhesion of human cancer cells.

Authors:  Youngeun Kwak; Jihyeung Ju
Journal:  Nutr Res Pract       Date:  2015-01-28       Impact factor: 1.926

10.  Autophagy inhibitor chloroquine enhanced the cell death inducing effect of the flavonoid luteolin in metastatic squamous cell carcinoma cells.

Authors:  Lien Verschooten; Kathleen Barrette; Sofie Van Kelst; Noemí Rubio Romero; Charlotte Proby; Rita De Vos; Patrizia Agostinis; Marjan Garmyn
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.